Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2025-12-24 @ 9:40 PM
NCT ID:
NCT00596232
Eligibility Criteria:
Inclusion Criteria:
Asthma:
1. Male and female subjects aged 18 - 70 years
2. Medical history consistent with asthma
3. PC20 (provocative concentration causing a 20% fall) methacholine ≤ 8 mg/ml for subjects not taking inhaled corticosteroids
4. PC20 methacholine ≤ 16 mg/ml for subjects taking inhaled corticosteroids
5. Ability to provide informed consent
Cystic Fibrosis:
1. Male and female subjects aged 18-55 years
2. Prior diagnosis of cystic fibrosis
3. Ability to provide informed consent
Healthy:
1. Male and female subjects aged 18-70 years
2. No current smoking history
3. No history of asthma or allergic rhinitis
4. FEV1 (forced expiratory volume in 1 second) \> 80% predicted
5. Ability to provide informed consent
Exclusion Criteria:
1. Recent heart attack or stroke
2. Known aortic or cerebral aneurysm
3. Uncontrolled hypertension
4. Pregnancy
5. Lactation
6. Lung disease other than asthma,cystic fibrosis, or chronic obstructive pulmonary disease (COPD)/emphysema/chronic bronchitis
7. Upper- or lower-respiratory tract infection 6 weeks prior to study enrollment
8. Significant asthma exacerbation 6 weeks prior to study enrollment
9. Increasing hyposensitization therapy for the past 3 months
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00596232
Study Brief:
Protocol Section:
NCT00596232